Nuwellis, Inc. , a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy.
Nuwellis stock last closed at $0.28, down 11.15% from the previous day, and has decreased 95.97% in one year. It has underperformed other stocks in the Medical Devices industry by 0.79 percentage points. Nuwellis stock is currently +32.23% from its 52-week low of $0.21, and -96.61% from its 52-week high of $8.23.
As of Jun 13, 2025, there are 4.37M NUWE shares outstanding. The market value of NUWE is $1.22M. In the past 24 hours, 8.44M NUWE shares were traded.
You will need a brokerage account to access the NASDAQ market and buy NUWE shares.
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, you'll need to fill out some personal info so you can buy NUWE stock today.
Now that you have finished signing up on one of the most highly reviewed stock market apps, you need to deposit funds:
Check out the video below for more details depositing funds into your new investment account.
Once you have figured out the best place to buy Nuwellis stock, it's very important to evaluate their stock prior to buying, so you can wrap your head around the risk as well as the opportunity.
WallStreetZen was built to help everyday investors perform better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on NUWE's stock page.
You can use many financial metrics, analyses, models, and charts to gauge NUWE's true value.
Using relative valuations ratios:
You can do more valuation research on NUWE's stock here.
You can dig deeper into what analysts are projecting on the Nuwellis stock forecast page.
Last year, NUWE revenue was $8.79M. During the last 5 year, NUWE's revenue has gone up by 8.2% per year. This was slower than the Medical Devices industry average of 9.62%.
Find out more about NUWE's earnings and revenue performance here.
Over the past 12 months, executives and large shareholders at NUWE have bought more shares than they have sold.
John L. Erb, CEO and President of NUWE, was the latest NUWE insider to buy. They bought $451.32 worth of NUWE shares on Jun 10, 2025.
Get more info about who owns NUWE stock here.
No, Nuwellis doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
You have two main types of orders:
Hit the Open Trade button and eToro will execute the order.
If you require more help with investing in stocks on eToro, watch the how to video below:
Now that you own some shares in NUWE, you'll want to stay up-to-date on your new investment.
Create a watchlist to get the latest updates about your NUWE stock.
To reiterate, here are the 6 steps you need to take to buy Nuwellis stock right now:
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Nuwellis, click the button below.